The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas

World Journal of Urology

Volumn 29, Issue 3, 2011, Pages 393-398

  Protzel, C ^a   Richter, M ^b   Poetsch, M ^c   Kakies, C ^a   Zimmermann, U ^b   Woenckhaus, C ^d   Klebingat, K J ^b   Hakenberg, O W ^a   Giebel, J ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d Institute of Pathology   (Germany)

Author keywords

Annexin; Metastasis; Penile carcinoma

Indexed keywords

LIPOCORTIN 1; LIPOCORTIN 2; LIPOCORTIN 4; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; DISEASE COURSE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PATHOPHYSIOLOGY; PENIS TUMOR; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A1; ANNEXIN A2; ANNEXIN A4; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PENILE NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79957525407     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0575-x     Document Type: Article

References (25)

1. Naumann CM, Alkatout I, Al-Najar A et al (2008) Lymph-node metastases in intermediate-risk squamous cell carcinoma of the penis. BJU Int 102: 1102-1106.
2. Campos RS, Lopes A, Guimaraes GC, Carvalho AL, Soares FA (2006) E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Urology 67: 797-802.
3. Mussunoor S, Murray GI (2008) The role of annexins in tumour development and progression. J Pathol 216: 131-140.
4. Masaki T, Tokuda M, Fujimura T et al (1994) Involvement of annexin I and annexin II in hepatocyte proliferation: can annexins I and II be markers for proliferative hepatocytes? Hepatology 20: 425-435.
5. Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS (2000) Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 267: 3220-3225.
6. Filipenko NR, MacLeod TJ, Yoon CS, Waisman DM (2004) Annexin A2 is a novel RNA-binding protein. J Biol Chem 279: 8723-8731.
7. Hajjar KA, Jacovina AT, Chacko J (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269: 21191-21197.
8. Esposito I, Penzel R, Chaib-Harrireche M et al (2006) Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol 208: 673-685.
9. Chung CY, Murphy-Ullrich JE, Erickson HP (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 7: 883-892.
10. Sohma H, Creutz CE, Saitoh M et al (1999) Characterization of the Ca2 + -dependent binding of annexin IV to surfactant protein A. Biochem J 341: 203-209.
11. Babbin BA, Lee WY, Parkos CA et al (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281: 19588-19599.
12. Wang KL, Wu TT, Resetkova E et al (2006) Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12: 4598-4604.
13. Zimmermann U, Woenckhaus C, Teller S et al (2007) Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. Histol Histopathol 22: 527-534.
14. Sharma MR, Koltowski L, Ownbey RT, Tuszynski GP, Sharma MC (2006) Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 81: 146-156.
15. Zimmermann U, Woenckhaus C, Pietschmann S et al (2004) Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch 445: 368-374.
16. Ohno Y, Izumi M, Kawamura T, et al. (2009) Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer [Epub ahead of print].
17. Zimmermann U, Balabanov S, Giebel J et al (2004) Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 209: 111-118.
18. Sobin LH, Wittekind C (2002) TNM Classification of malignant tumours, 6th edn. Wiley, New York.
19. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) Pathology and genetics of tumours of the urinary system and male genital organs. In: World Health Organization classification of tumours. IARC Press, Lyon, pp 280-290.
20. Lehnigk U, Zimmermann U, Woenckhaus C, Giebel J (2005) Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients. Histol Histopathol 20: 673-680.
21. Protzel C, Kakies C, Kleist B, Poetsch M, Giebel J (2008) Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Virchows Arch 452: 369-375.
22. Muneer A, Kayes O, Ahmed HU, Arya M, Minhas S (2009) Molecular prognostic factors in penile cancer. World J Urol 27: 161-167.
23. Gout S, Huot J (2008) Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 1: 69-83.
24. Flower RJ, Rothwell NJ (1994) Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15: 71-76.
25. Sakaguchi M, Murata H, Sonegawa H et al (2007) Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. J Biol Chem 282: 35679-35686.